Phase 1 trial of APD-418 for Decompensated heart failure
Latest Information Update: 21 Nov 2020
At a glance
- Drugs APD 418 (Primary)
- Indications Decompensated heart failure
- Focus Adverse reactions; First in man
- Sponsors Arena Pharmaceuticals
Most Recent Events
- 09 Nov 2020 Status changed from recruiting to completed, according to an Arena Pharmaceuticals media release.
- 05 Aug 2020 Status changed from suspended to recruiting.
- 05 Aug 2020 According to an Arena Pharmaceuticals media release, this trial has resumed